Share Price

follow quotes on

Major Shareholders

Update 23-12-2019

1
2
3
4
5
6
1

François Fornieri 1

27.88%

2

Free Float

36.62%

3

Marc Coucke 2

15.84%

4

Noshaq

12.30%

5

Bart Versluys 3

4.34%

6

Ogesip Invest SA

3.02%

(Shareholdership in accordance with transparency declarations received by the company and notified managers’ transactions)

1 François Fornieri holds warrants entitling him to subscribe 1,023,000 additional shares of Mithra through himself and 752,790 additional shares of Mithra through Yima SPRL, a company fully owned by François Fornieri.

2 Marc Coucke holds his shareholding partially through Alychlo NV, which he controls.

3  Bart Versluys holds his shareholding through Scorpiaux BVBA, controlled by Bart Versluys.

Voting Rights

Total number of voting rights (denominator)

39,133,245

(all relating to ordinary shares)

Total number of securities carrying voting rights

39,133,245

(all ordinary shares)

Total number of securities carrying voting rights not yet issued

1,023,000

(all related to warrants issued on 2 March 2015 and potentially to be exercised as from 2019)

1,333,395

(all related to warrants issued on 5 November 2018 and potentially to be exercised as from 5 November 2020)

Transparency Declarations

The Articles of the Association of Mithra Pharmaceuticals SA provide for an additional notification threshold of 3% of the total number of existing voting rights.

Alychlo NV

10 July 2020

OGESIP Invest SA

9 July 2020

OGESIP Invest SA

21 November 2017

Bart Versluys

29 December 2016

19 January 2016

François Fornieri

29 June 2018

11 July 2015

Meusinvest SA

29 June 2018

11 July 2015

Marc Coucke Alychlo NV

11 July 2015

OGEO Fund

21 November 2017

11 July 2015

Completed and signed forms should be sent to investorrelations@mithra.com

Analyst Coverage

Berenberg – Beatrice Allen
Degroof Petercam – Benoît Louage
KBC Securities – Sandra Cauwenberghs
Kempen
– Alexandru Cogut
Kepler Cheuvreux/Belfius – Pierre-Alexandre Desir
Portzamparc  – Christophe Dombu

Investor Factsheet

March 2020